Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

16.40
+0.70004.46%
Volume:4.70M
Turnover:77.51M
Market Cap:5.74B
PE:-16.89
High:17.25
Open:15.37
Low:15.37
Close:15.70
52wk High:24.28
52wk Low:1.53
Shares:349.76M
Float Shares:291.15M
Volume Ratio:3.93
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:15.85
PE(LYR):-37.34

Loading ...

Erasca Unveils Updated Cancer Candidate Progress, Maps Path Toward Pivotal Cancer Trials

Benzinga Earnings
·
Jul 15

Erasca 31.429M share Spot Secondary priced at $17.50

TIPRANKS
·
Jul 14

Erasca is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 14

Erasca price target raised to $18 from $16 at BofA

TIPRANKS
·
Jul 14

U.S. Stocks on the Move-lulu's Fashion Lounge Holdings, Wells Fargo, Bank of America

Reuters
·
Jul 14

Erasca Inc : Piper Sandler Raises Target Price to $22 from $18

THOMSON REUTERS
·
Jul 14

Cancer Biotech Erasca Down Premarket After $550 Mln Share Sale

Reuters
·
Jul 14

Analyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis

TIPRANKS
·
Jul 14

Erasca Plans to Fund R&D for Oncology Pipeline with Net Proceeds from USD 550 Million Stock Offering

Reuters
·
Jul 14

Erasca Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca - Prices Public Offering at $17.5 Per Share

THOMSON REUTERS
·
Jul 14

Erasca Shares Down 3.5% After the Bell; Announces Proposed Public Offering of $500 Mln of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca Plans USD 500 Million Common Stock Offering

Reuters
·
Jul 14

Erasca Reports 57% Preliminary Response Rate for Eras-0015 in 2L+ KRAS G12X Pancreatic Cancer Trial

Reuters
·
Jul 14

Erasca files automatic mixed securities shelf

TIPRANKS
·
Jul 14

Erasca Announces Proposed Public Offering of $500 Million of Common Stock

THOMSON REUTERS
·
Jul 14

Erasca Inc: Files for Mixed Shelf Offering, Size not Disclosed - Filing

THOMSON REUTERS
·
Jul 14

Erasca announces updated preliminary ERAS-0015 data

TIPRANKS
·
Jul 14

Erasca Announces Updated Preliminary Phase 1 Data and Registration-enabling Plans for Potentially Best-in-class Pan-ras Molecular Glue Eras-0015 in Kras-mutant Solid Tumors

THOMSON REUTERS
·
Jul 14

Erasca Inc: Additional Eras-0015 Monotherapy and Combination Data Expected H1 2027

THOMSON REUTERS
·
Jul 14